Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Sweden
  4. Nasdaq Stockholm
  5. Dignitana AB (publ.)
  6. News
  7. Summary
    DIGN   SE0002108001

DIGNITANA AB (PUBL.)

(DIGN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Dignitana : backed insurance legislation clears Texas House, progresses to Senate

04/16/2021 | 03:24pm EDT

Dignitana AB, world leader in scalp cooling innovation, announces today that HB1588, a Bill mandating insurance plan coverage for scalp cooling in Texas, was passed in the Texas House of Representatives on Friday. The Bill was introduced by Rep. Jeff Leach and 4 other legislators and now moves to the Texas Senate where it will be introduced by Sen. Angela Paxton as SB 862. Once passed in the Senate, the Bill then requires approval by Texas Governor Greg Abbott before being signed into law. If approved, it would take effect in September 2021.

Dignitana began working with Rep. Jeff Leach early in 2019 to initiate this legislation. In May 2019 a similar Bill was passed in the Texas House, but that legislative session ended before the Bill was brought to a vote. The Texas legislature only meets every other year.

"We were honored to work with Rep. Jeff Leach to get this legislation introduced and passed to provide cancer patients with coverage for scalp cooling," said William Cronin, CEO of Dignitana AB. "Removing financial barriers to scalp cooling is critical to our ability to help more patients, and we are happy to see the first steps being made in that direction right here in our home state of Texas."

For More Information Contact 

Melissa Bourestom, VP Corporate Communications,  melissa.bourestom@dignitana.com  +1 469-518-5031

About Dignitana

Dignitana AB is the world leader in clinically superior scalp cooling technology. The company produces The DigniCap® Scalp Cooling System, a patented medical cooling device that offers cancer patients the ability to minimize hair loss during chemotherapy. FDA cleared since 2015, DigniCap provides continuous cooling with high efficacy, safety and patient comfort. Hailed internationally as a life-changing medical advancement for cancer patients, The DigniCap Scalp Cooling System was invented in 1999 by a Swedish Oncology nurse and has been available in Europe since 2001.  Dignitana AB is listed on Nasdaq First North Growth Market in Sweden with headquarters in Lund, Sweden and operations based in Dallas, Texas in the United States.  Company subsidiaries are Dignitana, Inc. in the United States and Dignitana S.r.l. in Italy. Certified Adviser is Redeye AB +46 8 121 576 90, certifiedadviser@redeye.se. Learn more at www.dignitana.se or www.dignicap.com. 

https://news.cision.com/dignitana-ab/r/dignitana-backed-insurance-legislation-clears-texas-house--progresses-to-senate,c3327540

https://mb.cision.com/Main/2116/3327540/1402999.pdf

(c) 2021 Cision. All rights reserved., source Press Releases - English

All news about DIGNITANA AB (PUBL.)
06/23DIGNITANA  : launches new initiatives to support reimbursement and market access
AQ
06/18DIGNITANA  : publishes June newsletter
AQ
05/26DIGNITANA  : CEO William Cronin to speak at Småbolagsdagarna 2021
AQ
05/21DIGNITANA  : Q1'21 - Exciting Times Ahead
AQ
05/20DIGNITANA  : Bulletin from the Annual General Meeting of Dignitana AB (publ)
AQ
05/20DIGNITANA AB  : Publishes Q1 2021 Interim Report
AQ
04/16DIGNITANA  : backed insurance legislation clears Texas House, progresses to Sena..
AQ
04/16DIGNITANA  : publishes April newsletter
AQ
04/16DIGNITANA  : Notice of Annual General Meeting in Dignitana AB (Publ)
AQ
03/18DIGNITANA  : to address Stockholm Corporate Finance Life Science Seminar on Marc..
AQ
More news
Financials
Sales 2020 46,6 M 5,51 M 5,51 M
Net income 2020 -53,0 M -6,26 M -6,26 M
Net cash 2020 69,1 M 8,17 M 8,17 M
P/E ratio 2020 -8,59x
Yield 2020 -
Capitalization 491 M 57,9 M 58,0 M
EV / Sales 2019 11,3x
EV / Sales 2020 8,25x
Nbr of Employees 27
Free-Float 74,0%
Chart DIGNITANA AB (PUBL.)
Duration : Period :
Dignitana AB (publ.) Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers and Directors
William Cronin Chief Executive Officer & Director
James O. Mckinney President & Chief Operating Officer
Karin Almqvist Liwendahl Chief Financial Officer
Thomas N. Kelly Chairman
Klas Rune Arildsson Chairman
Sector and Competitors
1st jan.Capitalization (M$)
DIGNITANA AB (PUBL.)-8.50%58
NOVOCURE LIMITED30.36%23 328
MASIMO CORPORATION-10.69%13 184
PENUMBRA, INC.59.95%10 212
GETINGE AB64.86%10 170
SHOCKWAVE MEDICAL, INC.87.21%6 793